Table 1 Baseline patient characteristics (N = 709)
| Â | Overall | Manchester | Liverpool |
|---|---|---|---|
|  | (N = 709) | (n = 335) | (n = 374) |
Age in y, (mean, range) | 66.8 (27-93) | 65.1(27-90) | 68.4(31-93) |
Age ≥ 65, in % | 62.2 | 57.0 | 66.8 |
Gender, male % | 58.7 | 57.3 | 59.9 |
Smoking status, % | |||
Never smoker, % | 26.4 | 26.3 | 26.5 |
Ex-smoker, % | 41.3 | 41.5 | 41.2 |
Current smoker | 32.3 | 32.2 | 32.4 |
BMI, mean (median) | 27.7(27.1) | 27.6(27.1) | 27.7(27) |
Index event, in % | |||
Cerebral TIA | 43.7 | 44.5 | 43.1 |
Minor stroke | 42.3 | 51 | 34.5 |
Retinal TIA | 8.9 | 4.2 | 13.1 |
Retinal stroke | 5.1 | 0.3 | 9.4 |
Co- morbidity, % | |||
Previous stroke/TIA | 40.1 | 36.7 | 43.7 |
Coronary artery disease | 25.7 | 25.7 | 25.7 |
Hypertension | 70.2 | 73.1 | 67.7 |
Diabetes mellitus | 16.6 | 15.2 | 17.9 |
Medication use, % | |||
Aspirin | 73.8 | 74.9 | 72.7 |
Other antiplatelet drugs | 21.3 | 16.7 | 25.4 |
Statins | 54.6 | 55.5 | 53.7 |
Angiotensin converting enzyme inhibitor | 28.9 | 30.5 | 27.5 |
Angiotensin II receptor blocker | 10.3 | 11.0 | 9.6 |
Other anti-hypertensive medication | 50.1 | 50.5 | 49.7 |
Anti-anginal therapy | 17.9 | 17.6 | 18.2 |